Last reviewed · How we verify
PRP and PPP
At a glance
| Generic name | PRP and PPP |
|---|---|
| Sponsor | Gary M. Kiebzak, Ph.D. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Platelet Rich Plasma Injections In Young And Old Human Subjects (PHASE2)
- Autologous Alpha-2 Macroglobulin Rich Plasma, Safety and Efficacy in Symptomatic Moderate Knee Osteoarthritis (PHASE1, PHASE2)
- Ovarian Function Following Intraovarian Injection of PRP (NA)
- Regenerative Treatment of Female Genital Atrophy (PHASE1, PHASE2)
- Evaluation of the Effect of Biofiller PRP Application on Knee Osteoarthritis (NA)
- Autologous Platelet-Rich Plasma Therapy in the Treatment of Pyoderma Gangrenosum (NA)
- Successful Treatment of Female Pattern Hair Loss With Injection of Nanofat With and Without Platelet-Rich Plasma (NA)
- Comparison of the Effect of Combined Glenohumeral Joint and Subdeltoid Bursa Injection With Platelet-rich Plasma (PRP), Corticosteroid, and Normal Saline in Addition to Physical Therapy for Treatment of Frozen Shoulder (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PRP and PPP CI brief — competitive landscape report
- PRP and PPP updates RSS · CI watch RSS
- Gary M. Kiebzak, Ph.D. portfolio CI